Indian Metered Dose Inhaler Market Size, Share, Trends & Forecast 2019-2025

The Indian metered dose inhaler market is anticipated to grow at a substantial rate of around 8.0% during the forecast period. Major factors that augments the growth of the market include large population base susceptible to asthma and COPD, rising awareness about treatment for asthma and COPD, and significant presence of market players in the country. The Indian metered dose inhaler market is segmented based on type, application, and end-user. The preventive inhaler segment led the ****** metered dose inhaler market in 2018. Preventive inhalers are most widely used in the treatment of asthma in children and adults.

To learn more about Indian Metered Dose Inhaler Market report request a free sample copy @ https://www.omrglobal.com/request-sample/indian-metered-dose-inhaler-market

Preventive inhalers do not entail side effects for long-term use, and exceptionally decreases the possibility of an asthma exacerbation. The preventive inhalers further reduce the airways swelling and hence, are recommended for regular use by the physician. Some of the preventive inhalers available in the market include Budesonide and Fluticasone. Based on the type, preventive, reliever, and long-acting bronchodilators inhaler is analyzed. Moreover, based on the application, the market has been classified into asthma and COPD diseases. In addition, based on the end-user, homecare and hospitals and clinics have been analyzed.

Furthermore, the market is characterized by the presence of several manufacturers that are developing and providing metered dose inhalers to cater to a wide range of customers within the region and across the globe. The major players of the Indian metered dose inhaler market include 3M Co., AstraZeneca PLC, Aradigm Corp., Adherium Ltd., GlaxoSmithKline PLC, Novartis AG, Propeller Health, Teva Pharmaceuticals Industries Ltd. These players adopt various strategies to capitalize on market growth opportunities. Mergers and acquisitions, product launch, geographical expansion, partnerships, and collaborations are the majorly adopted strategies by the market players.

A full report of Indian Metered Dose Inhaler Market is available at https://www.omrglobal.com/industry-reports/indian-metered-dose-inhaler-market

Indian Metered Dose Inhaler Market Segmentation

By Type

  • Preventive Inhaler
  • Reliever Inhaler
  • Long Acting Bronchodilators Inhaler

By Application

  • Asthma
  • Chronic Obstructive Pulmonary Disease (COPD)

By End-User

  • Homecare
  • Hospitals and Clinics

Company Profiles

  • 3M Co.
  • Acorda Therapeutics, Inc.
  • Adamis Pharmaceuticals Corp.
  • Adherium Ltd.
  • Aradigm Corp.
  • AstraZeneca PLC
  • Beximo Pharmaceuticals Ltd.
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • GlaxoSmithKline PLC

For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/indian-metered-dose-inhaler-market

About us:

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

 

For More Information, Visit https://www.omrglobal.com/

 

Media Contact:

Company Name: Orion Market Research

Contact Person: Mr. Anurag Tiwari

Email: info@omrglobal.com

Contact no: +1 646-755-7667, +91 780-304-0404

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.